Malaysia vs Sri Lanka: Cause of death, by non-communicable diseases, ages 0-4
Malaysia
41.5%
in 2021
Sri Lanka
41.7%
in 2021
Malaysia rank
37th
Sri Lanka rank
35th
Cause of death, by non-communicable diseases, ages 0-4 over time
- Malaysia
- Sri Lanka
How they compare
Sri Lanka currently reports 41.7% against 41.5% in Malaysia, a difference of 0.2%.
The two have swapped places 1 time across 6 shared years of data; in 2000 it was Malaysia ahead.
Malaysia ranks 37th and Sri Lanka ranks 35th of 185 countries.
Malaysia has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Malaysia | Sri Lanka | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 40.7% | 35.2% | 5.5% | Malaysia |
| 2010s | 42.3% | 40.6% | 1.7% | Malaysia |
| 2020s | 42.1% | 42.0% | 0.0% | Malaysia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 0-4, Malaysia or Sri Lanka?
- Sri Lanka, at 41.7% against 41.5% in Malaysia as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 0-4 between Malaysia and Sri Lanka?
- 0.2%, with Sri Lanka ahead.
- How many years of comparable data are there for Malaysia and Sri Lanka?
- 6 years are reported by both, from 2000 to 2021.
- How do Malaysia and Sri Lanka rank globally for cause of death, by non-communicable diseases, ages 0-4?
- Malaysia ranks 37th and Sri Lanka ranks 35th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 0-4 (% of total deaths ages 0-4). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths ages 0-4 due to non-communicable diseases divided by number of all deaths ages 0-4, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.